TheraDoc vs VigiLanz (2026)
The two incumbent clinical surveillance platforms in American hospitals, and a comparison most pharmacy directors have run at least once at renewal. Both watch live laboratory, microbiology, pharmacy and admission feeds and raise alerts for stewardship, infection prevention and pharmacy surveillance, and both route those alerts to a pharmacist rather than acting on an order. VigiLanz reaches wider by setting, covering acute, post acute and ambulatory care, and ingests from any record system. TheraDoc publishes more about its own security posture, names national health information technology certification and third party testing, and covers mandatory infection reporting alongside stewardship. The important thing for a buyer is what neither is: both engines evaluate rules the hospital's own staff wrote, so the right diligence question is how those rules are validated and retired, not what the model accuracy is.
- Coverage is broadest by setting, spanning acute, post acute and ambulatory care, which is wider than its principal competitor and matters for a system that has grown beyond the hospital.
- Interoperability is the core competence rather than an add on, ingesting near real time clinical data regardless of which record system produced it, so a mixed estate is not an obstacle.
- Rules are customer configurable, so the institution's own pharmacists own the alert logic and can read every criterion that fires.
- The security page names three specific things rather than gesturing at them, including national health information technology certification and third party vulnerability testing, where the competitor publishes no attestation at all.
- Functional breadth within acute care is genuine, spanning infection prevention with mandatory reporting to the national surveillance network, antimicrobial stewardship, pharmacy surveillance and anticoagulation management in one platform.
- The alert path is clearly bounded: a clinical pharmacist or infection preventionist investigates and acts, and the platform never touches an order.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. TheraDoc and VigiLanz are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | TheraDoc | VigiLanz |
|---|---|---|
| Primary category | Medication Safety & Prescribing | Medication Safety & Prescribing |
| Founded | 1999 | 2001 |
| Headquarters | Salt Lake City, Utah, United States | Minneapolis, Minnesota, United States |
| Website | solutions.premierinc.com | inovalon.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index records no top capability grade for TheraDoc on any axis it scores. Set against VigiLanz, TheraDoc grades higher on several axes, including Model and Technology Transparency, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Its thinnest published disclosure sits on AI Centrality, AI Governance and Bias Disclosure and Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index records no top capability grade for VigiLanz on any axis it scores. Set against TheraDoc, VigiLanz does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, Autonomy and Oversight Model and Model Supply Chain Disclosure. Its thinnest published disclosure sits on several axes, including AI Centrality, HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose TheraDoc or VigiLanz?
The AI Health Index grades TheraDoc higher than VigiLanz on every axis that separates them, several axes, including Model and Technology Transparency, AI Safety and PHI Stewardship and HIPAA and BAA Posture. VigiLanz does not grade higher on any scored axis.
Where do TheraDoc and VigiLanz differ most?
The widest separation the AI Health Index records between TheraDoc and VigiLanz is on HIPAA and BAA Posture, where TheraDoc grades B and VigiLanz grades D. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do TheraDoc and VigiLanz grade the same?
The AI Health Index grades TheraDoc and VigiLanz the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have TheraDoc and VigiLanz not disclosed?
At the last review, at least one of TheraDoc and VigiLanz published thin or absent detail on several axes, including AI Centrality, HIPAA and BAA Posture and Security Certifications and Trust Center. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both vendors describe their engines in AI terms and both are rules engines. One product page uses the phrase flexible rule based AI, which is the clearest instance in this index of the label being applied to logic a hospital's own staff wrote. That is not a criticism of the products, since a rules engine is transparent by construction and a learned model is not, but it should change what a buyer asks for: rule validation methodology rather than model accuracy.
Neither publishes performance by patient characteristic, a rule validation method or a post deployment monitoring statement. VigiLanz publishes no located security attestation, trust centre or business associate terms. Neither publishes pricing.